BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruiz M, Déglon N. Viral-mediated overexpression of mutant huntingtin to model HD in various species. Neurobiol Dis 2012;48:202-11. [PMID: 21889981 DOI: 10.1016/j.nbd.2011.08.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Cresto N, Gaillard MC, Gardier C, Gubinelli F, Diguet E, Bellet D, Legroux L, Mitja J, Auregan G, Guillermier M, Josephine C, Jan C, Dufour N, Joliot A, Hantraye P, Bonvento G, Déglon N, Bemelmans AP, Cambon K, Liot G, Brouillet E. The C-terminal domain of LRRK2 with the G2019S mutation is sufficient to produce neurodegeneration of dopaminergic neurons in vivo. Neurobiol Dis 2020;134:104614. [PMID: 31605779 DOI: 10.1016/j.nbd.2019.104614] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
2 Galvan L, Francelle L, Gaillard MC, de Longprez L, Carrillo-de Sauvage MA, Liot G, Cambon K, Stimmer L, Luccantoni S, Flament J, Valette J, de Chaldée M, Auregan G, Guillermier M, Joséphine C, Petit F, Jan C, Jarrige M, Dufour N, Bonvento G, Humbert S, Saudou F, Hantraye P, Merienne K, Bemelmans AP, Perrier AL, Déglon N, Brouillet E. The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin. Brain 2018;141:1434-54. [PMID: 29534157 DOI: 10.1093/brain/awy057] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
3 Puhl DL, D'Amato AR, Gilbert RJ. Challenges of gene delivery to the central nervous system and the growing use of biomaterial vectors. Brain Res Bull 2019;150:216-30. [PMID: 31173859 DOI: 10.1016/j.brainresbull.2019.05.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
4 Jang M, Lee SE, Cho IH. Adeno-Associated Viral Vector Serotype DJ-Mediated Overexpression of N171-82Q-Mutant Huntingtin in the Striatum of Juvenile Mice Is a New Model for Huntington's Disease. Front Cell Neurosci 2018;12:157. [PMID: 29946240 DOI: 10.3389/fncel.2018.00157] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
5 Ceccarelli I, Fiengo P, Remelli R, Miragliotta V, Rossini L, Biotti I, Cappelli A, Petricca L, La Rosa S, Caricasole A, Pollio G, Scali C. Recombinant Adeno Associated Viral (AAV) vector type 9 delivery of Ex1-Q138-mutant huntingtin in the rat striatum as a short-time model for in vivo studies in drug discovery. Neurobiology of Disease 2016;86:41-51. [DOI: 10.1016/j.nbd.2015.11.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
6 Fox J, Lu Z, Barrows L. Thiol-disulfide Oxidoreductases TRX1 and TMX3 Decrease Neuronal Atrophy in a Lentiviral Mouse Model of Huntington's Disease. PLoS Curr 2015;7:ecurrents. [PMID: 26664998 DOI: 10.1371/currents.hd.b966ec2eca8e2d89d2bb4d020be4351e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Ben Haim L, Ceyzériat K, Carrillo-de Sauvage MA, Aubry F, Auregan G, Guillermier M, Ruiz M, Petit F, Houitte D, Faivre E, Vandesquille M, Aron-Badin R, Dhenain M, Déglon N, Hantraye P, Brouillet E, Bonvento G, Escartin C. The JAK/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer's and Huntington's diseases. J Neurosci 2015;35:2817-29. [PMID: 25673868 DOI: 10.1523/JNEUROSCI.3516-14.2015] [Cited by in Crossref: 135] [Cited by in F6Publishing: 143] [Article Influence: 19.3] [Reference Citation Analysis]
8 Francelle L, Galvan L, Gaillard MC, Petit F, Bernay B, Guillermier M, Bonvento G, Dufour N, Elalouf JM, Hantraye P, Déglon N, de Chaldée M, Brouillet E. Striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo. Neurobiol Aging 2015;36:1601.e7-16. [PMID: 25619660 DOI: 10.1016/j.neurobiolaging.2014.11.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
9 Francelle L, Galvan L, Gaillard MC, Guillermier M, Houitte D, Bonvento G, Petit F, Jan C, Dufour N, Hantraye P, Elalouf JM, De Chaldée M, Déglon N, Brouillet E. Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's disease. Hum Mol Genet 2015;24:1563-73. [PMID: 25398949 DOI: 10.1093/hmg/ddu571] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
10 Damiano M, Diguet E, Malgorn C, D'Aurelio M, Galvan L, Petit F, Benhaim L, Guillermier M, Houitte D, Dufour N, Hantraye P, Canals JM, Alberch J, Delzescaux T, Déglon N, Beal MF, Brouillet E. A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin. Hum Mol Genet 2013;22:3869-82. [PMID: 23720495 DOI: 10.1093/hmg/ddt242] [Cited by in Crossref: 69] [Cited by in F6Publishing: 72] [Article Influence: 7.7] [Reference Citation Analysis]
11 Gao J, Zhang C, Fu X, Yi Q, Tian F, Ning Q, Luo X. Effects of targeted suppression of glutaryl-CoA dehydrogenase by lentivirus-mediated shRNA and excessive intake of lysine on apoptosis in rat striatal neurons. PLoS One 2013;8:e63084. [PMID: 23658800 DOI: 10.1371/journal.pone.0063084] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
12 Ehrlich ME. Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease. Neurotherapeutics 2012;9:270-84. [PMID: 22441874 DOI: 10.1007/s13311-012-0112-2] [Cited by in Crossref: 77] [Cited by in F6Publishing: 81] [Article Influence: 8.6] [Reference Citation Analysis]